Search results
Pharma stock jumps 8% after company filed its first drug to treat blood volume loss with USFDA
Investing.com· 4 days agoWith a market capitalization of Rs. 4,683.21 Crores, the shares of Shilpa Medicare (NS: SHME )...
The 5 Biggest Early Warning Signs Of Liver Damage
HuffPost Life via Yahoo News· 3 days agoBruising and bleeding easily People with liver damage may bruise or bleed easily when injured, Weine said. This happens because the liver produces...
NIH AI tool predicts cancer patients’ immunotherapy outcomes
Pharmaceutical Technology via Yahoo Finance· 4 days agoBut these markers do not consistently forecast treatment responses. Unlike previous models that rely...
Everything You Need to Know About Metabolic Acidosis
Verywell Health via Yahoo News· 2 days agoMetabolic acidosis is a condition in which acid builds up in the body due to a problem in your cells that throws off the chemical balance in your blood....
NIH, MSKCC researchers publish AI model for predicting immunotherapy responses
FierceBiotech· 4 days agoThe AI model incorporates five clinical features gathered from a routine workup and blood testing:...
AI tool helps determine if immunotherapy drugs are effective for treating a patient’s cancer
National Cancer Institute· 5 days agoIn a proof-of-concept study, researchers at the National Institutes of Health (NIH) have developed...
Nonvisible Hematuria: Management Guidance in Primary Care
Medscape· 3 days agoLinda, a 50-year-old hedge fund manager, consults you in clinic after her recent annual company health screen detected 2+ blood on her urine dipstick test. Linda's health ...
Can money conquer death? How wealthy people are trying to live forever
Los Angeles Times· 4 days ago“Here” is a sixth-floor doctor’s office in Santa Monica, where the XPrize founder has been coming...
Fine Particulate Matter Raises Type 2 Diabetes Risk in Women
Medscape· 3 days agoLong-term exposure to fine particulate matter increased type 2 diabetes in women of childbearing...
AbbVie Announces Positive Topline Results from Phase 2 PICCOLO Trial Evaluating Mirvetuximab...
The Parsons Sun· 2 days agoPICCOLO trial met its primary endpoint of objective response rate (ORR)Data from the study will be presented at a future medical meeting